Packard CJ - Search Results

1

Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM.

Malmström R, Packard CJ, Caslake M, Bedford D, Stewart P, Yki-Järvinen H, Shepherd J, Taskinen MR. Malmström R, et al. Among authors: packard cj. Diabetologia. 1997 Apr;40(4):454-62. doi: 10.1007/s001250050700. Diabetologia. 1997. PMID: 9112023

2

Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance.

Adiels M, Westerbacka J, Soro-Paavonen A, Häkkinen AM, Vehkavaara S, Caslake MJ, Packard C, Olofsson SO, Yki-Järvinen H, Taskinen MR, Borén J. Adiels M, et al. Diabetologia. 2007 Nov;50(11):2356-65. doi: 10.1007/s00125-007-0790-1. Epub 2007 Sep 12. Diabetologia. 2007. PMID: 17849096

3

Metabolism of HDL apolipoprotein A-I and A-II in type 1 (insulin-dependent) diabetes mellitus.

Taskinen MR, Kahri J, Koivisto V, Shepherd J, Packard CJ. Taskinen MR, et al. Among authors: packard cj. Diabetologia. 1992 Apr;35(4):347-56. doi: 10.1007/BF00401202. Diabetologia. 1992. PMID: 1516763

4

Effect of insulin therapy on metabolic fate of apolipoprotein B-containing lipoproteins in NIDDM.

Taskinen MR, Packard CJ, Shepherd J. Taskinen MR, et al. Among authors: packard cj. Diabetes. 1990 Sep;39(9):1017-27. doi: 10.2337/diab.39.9.1017. Diabetes. 1990. PMID: 2200727

5

Metabolic basis of hypotriglyceridemic effects of insulin in normal men.

Malmström R, Packard CJ, Watson TD, Rannikko S, Caslake M, Bedford D, Stewart P, Yki-Järvinen H, Shepherd J, Taskinen MR. Malmström R, et al. Among authors: packard cj. Arterioscler Thromb Vasc Biol. 1997 Jul;17(7):1454-64. doi: 10.1161/01.atv.17.7.1454. Arterioscler Thromb Vasc Biol. 1997. PMID: 9261280

6

Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects.

Malmström R, Packard CJ, Caslake M, Bedford D, Stewart P, Yki-Järvinen H, Shepherd J, Taskinen MR. Malmström R, et al. Among authors: packard cj. Diabetes. 1998 May;47(5):779-87. doi: 10.2337/diabetes.47.5.779. Diabetes. 1998. PMID: 9588450 Clinical Trial.

7

Effect of heparin-stimulated plasma lipolytic activity on VLDL APO B subclass metabolism in normal subjects.

Malmström R, Packard CJ, Caslake M, Bedford D, Stewart P, Shepherd J, Taskinen MR. Malmström R, et al. Among authors: packard cj. Atherosclerosis. 1999 Oct;146(2):381-90. doi: 10.1016/s0021-9150(99)00153-7. Atherosclerosis. 1999. PMID: 10532694 Clinical Trial.

8

Overproduction of large VLDL particles is driven by increased liver fat content in man.

Adiels M, Taskinen MR, Packard C, Caslake MJ, Soro-Paavonen A, Westerbacka J, Vehkavaara S, Häkkinen A, Olofsson SO, Yki-Järvinen H, Borén J. Adiels M, et al. Diabetologia. 2006 Apr;49(4):755-65. doi: 10.1007/s00125-005-0125-z. Epub 2006 Feb 4. Diabetologia. 2006. PMID: 16463046

9

Plasma triglyceride and low density lipoprotein metabolism.

Caslake MJ, Packard CJ, Series JJ, Yip B, Dagen MM, Shepherd J. Caslake MJ, et al. Among authors: packard cj. Eur J Clin Invest. 1992 Feb;22(2):96-104. doi: 10.1111/j.1365-2362.1992.tb01942.x. Eur J Clin Invest. 1992. PMID: 1572392

10

In vivo metabolism of apo A-I and apo A-II in subjects with apo A-I(Lys107-->0) associated with reduced HDL cholesterol and Lp(AI w AII) deficiency.

Tilly-Kiesi M, Packard CJ, Kahri J, Ehnholm C, Shepherd J, Taskinen MR. Tilly-Kiesi M, et al. Among authors: packard cj. Atherosclerosis. 1997 Feb 10;128(2):213-22. doi: 10.1016/s0021-9150(96)05992-8. Atherosclerosis. 1997. PMID: 9050778

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

430 results

Search Page

Filters